生物相容的天然聚合物和尖端的制造技术在开发下一代口腔薄膜的增强药物输送系统
Siddhi Wargantiwar1, Sankha Bhattacharya1
1School of Pharmacy & Technology Management, SVKM'S NMIMS Deemed-to-be University, Shirpur, Maharashtra 425405, India.
Current pharmaceutical design
|October 10, 2024
概括
奇托,凝和普鲁兰等天然聚合物为口腔薄膜 (OTF) 提供安全,可生物降解的选择. 新的制造方法提高了药物输送,改善了患者的遵守性,并创造了环保的解决方案.
科学领域:
- 制药科学 制药科学
- 材料科学 材料科学 材料科学
- 生物技术是生物技术.
背景情况:
- 口腔薄膜 (OTF) 代表了一种先进的药物输送系统,增强了患者的便利性和遵守性.
- 自然聚合物越来越多地被用于OTF配方,因为它们的生物相容性和生物降解性.
- 奇托,凝和普鲁兰是开发安全有效的OTF的有希望的天然聚合物.
研究的目的:
- 审查自然聚合物的潜力,在设计先进的口腔薄膜.
- 探索超越OTF生产传统方法的新型制造技术.
- 弥合自然聚合物应用与下一代药物输送的创新制造工艺之间的差距.
主要方法:
- 关于用于口腔薄膜应用的天然聚合物 (奇托桑,凝,普鲁兰) 的文献综述.
- 研究先进的制造技术,包括溶剂造,热挤出和制方法.
- 分析控制薄膜特性和优化药物释放特征的策略.
主要成果:
- 天然聚合物为口服薄膜配方提供生物相容,可生物降解和安全的替代品.
- 先进的制造技术可以精确控制膜的特性,从而实现量身定制的药物输送.
- 天然聚合物和新型制造工艺的组合显示出提高药物疗效和患者接受度的潜力.
结论:
- 天然聚合物非常适合开发患者友好和环境可持续的口腔薄膜.
- 创新的制造技术对于实现基于天然聚合物的OTF的全部潜力至关重要.
- 这项研究强调了下一代口服药物输送系统的有希望的途径,其性能和合规性得到了提高.
更多相关视频
08:17An Additive Manufacturing Technique for the Facile and Rapid Fabrication of Hydrogel-based Micromachines with Magnetically Responsive Components
Published on: July 18, 2018
7.1K
09:39Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
Published on: February 7, 2021
7.8K
相关概念视频
01:27Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:23Oral Drug Delivery Systems: Introduction
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
01:26Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
01:11Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...